A032940 Stock Overview
Wonik Corporation engages in the semiconductor, trade and distribution, finance, electric and electronics, and leisure businesses in South Korea.
Price History & Performance
|Historical stock prices|
|Current Share Price||₩4,415.00|
|52 Week High||₩6,150.00|
|52 Week Low||₩3,850.00|
|1 Month Change||-10.81%|
|3 Month Change||2.91%|
|1 Year Change||-18.69%|
|3 Year Change||8.61%|
|5 Year Change||-29.25%|
|Change since IPO||-11.35%|
Recent News & Updates
I Ran A Stock Scan For Earnings Growth And Wonik (KOSDAQ:032940) Passed With Ease
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Reflecting on Wonik's (KOSDAQ:032940) Share Price Returns Over The Last Five Years
While not a mind-blowing move, it is good to see that the Wonik Corporation ( KOSDAQ:032940 ) share price has gained...
|A032940||KR Healthcare||KR Market|
Return vs Industry: A032940 exceeded the KR Healthcare industry which returned -40.8% over the past year.
Return vs Market: A032940 underperformed the KR Market which returned -14.3% over the past year.
|A032940 Average Weekly Movement||3.3%|
|Healthcare Industry Average Movement||6.0%|
|Market Average Movement||5.4%|
|10% most volatile stocks in KR Market||10.2%|
|10% least volatile stocks in KR Market||3.1%|
Stable Share Price: A032940 is less volatile than 75% of KR stocks over the past 3 months, typically moving +/- 3% a week.
Volatility Over Time: A032940's weekly volatility (3%) has been stable over the past year.
About the Company
Wonik Corporation engages in the semiconductor, trade and distribution, finance, electric and electronics, and leisure businesses in South Korea. The company offers process devices building circuits on substrate boards; dry etcher in black plane and thin film encapsulation; thin film solar cell equipment; quartz ware products; ceramics; lamps; semiconductor precision cleaning equipment; precursor; gas supply, purification, and monitoring systems; precursor supply systems; and plumbing construction. It also trades in medical devices, such as beauty equipment, and surgical devices and instruments; industrial raw materials and lighting-related products; chemical products of paints, inks, adhesives, papers, artificial marble, electron materials, and synthetic leather and fabrics; engineered plastics and silicon products; building materials; lipid components; and commercial and industrial printing and printers, as well as offers related management education, technical support, software upgrade, and consumable parts.
Wonik Fundamentals Summary
|A032940 fundamental statistics|
Is A032940 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|A032940 income statement (TTM)|
|Cost of Revenue||₩52.52b|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
|Earnings per share (EPS)||1.57k|
|Net Profit Margin||30.09%|
How did A032940 perform over the long term?See historical performance and comparison
Is Wonik undervalued compared to its fair value and its price relative to the market?
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: A032940 (₩4415) is trading below our estimate of fair value (₩7053.09)
Significantly Below Fair Value: A032940 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: A032940 is good value based on its Price-To-Earnings Ratio (2.8x) compared to the Asian Healthcare industry average (17.5x).
PE vs Market: A032940 is good value based on its Price-To-Earnings Ratio (2.8x) compared to the KR market (14.1x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate A032940's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: A032940 is good value based on its Price-To-Book Ratio (0.4x) compared to the KR Healthcare industry average (2.3x).
How is Wonik forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Wonik has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Wonik performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: A032940 has high quality earnings.
Growing Profit Margin: A032940's current net profit margins (30.1%) are lower than last year (90.7%).
Past Earnings Growth Analysis
Earnings Trend: A032940's earnings have grown by 14.6% per year over the past 5 years.
Accelerating Growth: A032940's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: A032940 had negative earnings growth (-64.1%) over the past year, making it difficult to compare to the Healthcare industry average (33.2%).
Return on Equity
High ROE: A032940's Return on Equity (13.2%) is considered low.
How is Wonik's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: A032940's short term assets (₩28.3B) do not cover its short term liabilities (₩39.4B).
Long Term Liabilities: A032940's short term assets (₩28.3B) do not cover its long term liabilities (₩60.4B).
Debt to Equity History and Analysis
Debt Level: A032940's net debt to equity ratio (12.8%) is considered satisfactory.
Reducing Debt: A032940's debt to equity ratio has reduced from 38.3% to 16.3% over the past 5 years.
Debt Coverage: A032940's debt is well covered by operating cash flow (23.2%).
Interest Coverage: A032940's interest payments on its debt are well covered by EBIT (7x coverage).
What is Wonik current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate A032940's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A032940's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if A032940's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A032940's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A032940 has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Cha Yik (62 yo)
Cha Dong Yik has been Chief Executive Officer of Wonik Corporation since September 30, 2011 and serves as its Managing Director. Cha Dong Yik serves as Director of Wonik Corporation. Cha Dong-Ik served as...
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Wonik Corporation's employee growth, exchange listings and data sources
- Name: Wonik Corporation
- Ticker: A032940
- Exchange: KOSDAQ
- Founded: 1981
- Industry: Health Care Distributors
- Sector: Healthcare
- Implied Market Cap: ₩82.688b
- Shares outstanding: 18.19m
- Website: https://www.wonik.com
Number of Employees
- Wonik Corporation
- 20, Pangyo-ro
- 255 beon-gil
- South Korea
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/24 00:00|
|End of Day Share Price||2022/05/24 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.